MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--June 8, 2006--ChemGenex Pharmaceuticals (ASX: CXS, NASDAQ: CXSP) announced that its Senior Director of Statistical Genomics, John Blangero Ph.D. will present new data on the PSARL gene at the Annual Meeting of the American Diabetes Association in Washington, D.C., USA on Monday, June 12, 2006. Dr Blangero’s presentation will form part of an expert Symposium on Mitochondrial Dysfunction.
